nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—Liothyronine—hypothyroidism	0.137	0.206	CbGbCtD
Gefitinib—ALB—Levothyroxine—hypothyroidism	0.137	0.206	CbGbCtD
Gefitinib—ALB—Liotrix—hypothyroidism	0.134	0.201	CbGbCtD
Gefitinib—ABCB1—Levothyroxine—hypothyroidism	0.0717	0.108	CbGbCtD
Gefitinib—ABCB1—Liothyronine—hypothyroidism	0.0717	0.108	CbGbCtD
Gefitinib—ABCB1—Liotrix—hypothyroidism	0.07	0.105	CbGbCtD
Gefitinib—CYP3A4—Levothyroxine—hypothyroidism	0.043	0.0647	CbGbCtD
Gefitinib—HIPK4—gonad—hypothyroidism	0.00382	0.0168	CbGeAlD
Gefitinib—Arrhythmia—Liothyronine—hypothyroidism	0.00378	0.0399	CcSEcCtD
Gefitinib—SBK1—pituitary gland—hypothyroidism	0.00377	0.0166	CbGeAlD
Gefitinib—CYP2C19—urine—hypothyroidism	0.00371	0.0164	CbGeAlD
Gefitinib—Tenderness—Liotrix—hypothyroidism	0.00349	0.0368	CcSEcCtD
Gefitinib—SBK1—blood—hypothyroidism	0.00336	0.0148	CbGeAlD
Gefitinib—CHEK2—pituitary gland—hypothyroidism	0.00328	0.0145	CbGeAlD
Gefitinib—SBK1—thyroid gland—hypothyroidism	0.00325	0.0143	CbGeAlD
Gefitinib—Ulcer—Liotrix—hypothyroidism	0.00322	0.034	CcSEcCtD
Gefitinib—EPHA6—gonad—hypothyroidism	0.00302	0.0133	CbGeAlD
Gefitinib—CHEK2—adrenal gland—hypothyroidism	0.00293	0.0129	CbGeAlD
Gefitinib—CHEK2—blood—hypothyroidism	0.00293	0.0129	CbGeAlD
Gefitinib—CYP2C9—urine—hypothyroidism	0.00288	0.0127	CbGeAlD
Gefitinib—CHEK2—thyroid gland—hypothyroidism	0.00283	0.0125	CbGeAlD
Gefitinib—Hypotension—Liothyronine—hypothyroidism	0.00281	0.0297	CcSEcCtD
Gefitinib—Dehydration—Levothyroxine—hypothyroidism	0.00279	0.0295	CcSEcCtD
Gefitinib—Dehydration—Dextrothyroxine—hypothyroidism	0.00279	0.0295	CcSEcCtD
Gefitinib—SBK1—testis—hypothyroidism	0.00278	0.0123	CbGeAlD
Gefitinib—HIPK4—testis—hypothyroidism	0.00275	0.0121	CbGeAlD
Gefitinib—CHEK2—female gonad—hypothyroidism	0.00273	0.0121	CbGeAlD
Gefitinib—EGFR—heart—hypothyroidism	0.00259	0.0114	CbGeAlD
Gefitinib—CSNK1E—adrenal cortex—hypothyroidism	0.00257	0.0114	CbGeAlD
Gefitinib—SBK1—cerebellum—hypothyroidism	0.00257	0.0113	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—hypothyroidism	0.00253	0.0112	CbGeAlD
Gefitinib—CSNK1E—heart—hypothyroidism	0.00249	0.011	CbGeAlD
Gefitinib—IRAK4—heart—hypothyroidism	0.00245	0.0108	CbGeAlD
Gefitinib—CHEK2—testis—hypothyroidism	0.00242	0.0107	CbGeAlD
Gefitinib—ERBB3—heart—hypothyroidism	0.0024	0.0106	CbGeAlD
Gefitinib—Body temperature increased—Liothyronine—hypothyroidism	0.00238	0.0251	CcSEcCtD
Gefitinib—MKNK2—adrenal cortex—hypothyroidism	0.00236	0.0104	CbGeAlD
Gefitinib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00235	0.0248	CcSEcCtD
Gefitinib—Weight decreased—Levothyroxine—hypothyroidism	0.00235	0.0248	CcSEcCtD
Gefitinib—MKNK1—adrenal cortex—hypothyroidism	0.00233	0.0103	CbGeAlD
Gefitinib—MKNK2—heart—hypothyroidism	0.00228	0.0101	CbGeAlD
Gefitinib—IRAK1—heart—hypothyroidism	0.00228	0.0101	CbGeAlD
Gefitinib—MKNK1—heart—hypothyroidism	0.00226	0.00995	CbGeAlD
Gefitinib—CYP3A4—urine—hypothyroidism	0.00219	0.00968	CbGeAlD
Gefitinib—EPHA6—testis—hypothyroidism	0.00217	0.00959	CbGeAlD
Gefitinib—CYP2D6—urine—hypothyroidism	0.00216	0.00952	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—hypothyroidism	0.00216	0.00951	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—hypothyroidism	0.00213	0.00939	CbGeAlD
Gefitinib—CSNK1E—pituitary gland—hypothyroidism	0.00208	0.00917	CbGeAlD
Gefitinib—Dehydration—Liotrix—hypothyroidism	0.00205	0.0217	CcSEcCtD
Gefitinib—IRAK4—pituitary gland—hypothyroidism	0.00205	0.00903	CbGeAlD
Gefitinib—Hypokalaemia—Liotrix—hypothyroidism	0.00201	0.0212	CcSEcCtD
Gefitinib—MAP3K19—testis—hypothyroidism	0.00198	0.00872	CbGeAlD
Gefitinib—MKNK2—gonad—hypothyroidism	0.00196	0.00863	CbGeAlD
Gefitinib—EGFR—adrenal gland—hypothyroidism	0.00193	0.00852	CbGeAlD
Gefitinib—MKNK1—gonad—hypothyroidism	0.00193	0.00852	CbGeAlD
Gefitinib—MKNK2—pituitary gland—hypothyroidism	0.00191	0.00842	CbGeAlD
Gefitinib—MKNK1—pituitary gland—hypothyroidism	0.00188	0.00831	CbGeAlD
Gefitinib—EGFR—thyroid gland—hypothyroidism	0.00187	0.00822	CbGeAlD
Gefitinib—CSNK1E—adrenal gland—hypothyroidism	0.00186	0.0082	CbGeAlD
Gefitinib—CSNK1E—blood—hypothyroidism	0.00186	0.00819	CbGeAlD
Gefitinib—STK10—heart—hypothyroidism	0.00186	0.00819	CbGeAlD
Gefitinib—Arrhythmia—Levothyroxine—hypothyroidism	0.00186	0.0196	CcSEcCtD
Gefitinib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00186	0.0196	CcSEcCtD
Gefitinib—Alopecia—Dextrothyroxine—hypothyroidism	0.00184	0.0194	CcSEcCtD
Gefitinib—Alopecia—Levothyroxine—hypothyroidism	0.00184	0.0194	CcSEcCtD
Gefitinib—IRAK4—adrenal gland—hypothyroidism	0.00183	0.00807	CbGeAlD
Gefitinib—IRAK4—blood—hypothyroidism	0.00183	0.00807	CbGeAlD
Gefitinib—EGFR—female gonad—hypothyroidism	0.0018	0.00795	CbGeAlD
Gefitinib—CSNK1E—thyroid gland—hypothyroidism	0.00179	0.00791	CbGeAlD
Gefitinib—IRAK4—thyroid gland—hypothyroidism	0.00177	0.00779	CbGeAlD
Gefitinib—STK10—cardiovascular system—hypothyroidism	0.00175	0.00773	CbGeAlD
Gefitinib—CSNK1E—female gonad—hypothyroidism	0.00173	0.00764	CbGeAlD
Gefitinib—ERBB3—thyroid gland—hypothyroidism	0.00173	0.00763	CbGeAlD
Gefitinib—Weight decreased—Liotrix—hypothyroidism	0.00173	0.0182	CcSEcCtD
Gefitinib—MAP2K5—adrenal cortex—hypothyroidism	0.00172	0.00756	CbGeAlD
Gefitinib—IRAK4—female gonad—hypothyroidism	0.00171	0.00752	CbGeAlD
Gefitinib—MKNK2—adrenal gland—hypothyroidism	0.00171	0.00752	CbGeAlD
Gefitinib—IRAK1—adrenal gland—hypothyroidism	0.00171	0.00752	CbGeAlD
Gefitinib—MKNK2—blood—hypothyroidism	0.0017	0.00752	CbGeAlD
Gefitinib—IRAK1—blood—hypothyroidism	0.0017	0.00752	CbGeAlD
Gefitinib—MKNK1—adrenal gland—hypothyroidism	0.00168	0.00743	CbGeAlD
Gefitinib—MKNK1—blood—hypothyroidism	0.00168	0.00742	CbGeAlD
Gefitinib—ERBB3—female gonad—hypothyroidism	0.00167	0.00737	CbGeAlD
Gefitinib—MAP2K5—heart—hypothyroidism	0.00166	0.00732	CbGeAlD
Gefitinib—Angioedema—Dextrothyroxine—hypothyroidism	0.00165	0.0175	CcSEcCtD
Gefitinib—Angioedema—Levothyroxine—hypothyroidism	0.00165	0.0175	CcSEcCtD
Gefitinib—MKNK2—thyroid gland—hypothyroidism	0.00165	0.00726	CbGeAlD
Gefitinib—IRAK1—thyroid gland—hypothyroidism	0.00165	0.00726	CbGeAlD
Gefitinib—MKNK1—thyroid gland—hypothyroidism	0.00162	0.00717	CbGeAlD
Gefitinib—EGFR—testis—hypothyroidism	0.0016	0.00705	CbGeAlD
Gefitinib—STK10—gonad—hypothyroidism	0.00159	0.00702	CbGeAlD
Gefitinib—MKNK2—female gonad—hypothyroidism	0.00159	0.00701	CbGeAlD
Gefitinib—IRAK1—female gonad—hypothyroidism	0.00159	0.00701	CbGeAlD
Gefitinib—MKNK1—female gonad—hypothyroidism	0.00157	0.00692	CbGeAlD
Gefitinib—MAP2K5—cardiovascular system—hypothyroidism	0.00157	0.0069	CbGeAlD
Gefitinib—CSNK1E—testis—hypothyroidism	0.00154	0.00678	CbGeAlD
Gefitinib—IRAK4—testis—hypothyroidism	0.00151	0.00667	CbGeAlD
Gefitinib—EGFR—liver—hypothyroidism	0.00151	0.00666	CbGeAlD
Gefitinib—ERBB3—testis—hypothyroidism	0.00148	0.00654	CbGeAlD
Gefitinib—EGFR—cerebellum—hypothyroidism	0.00148	0.00651	CbGeAlD
Gefitinib—CSNK1E—liver—hypothyroidism	0.00145	0.00641	CbGeAlD
Gefitinib—Shock—Dextrothyroxine—hypothyroidism	0.00145	0.0153	CcSEcCtD
Gefitinib—Shock—Levothyroxine—hypothyroidism	0.00145	0.0153	CcSEcCtD
Gefitinib—IRAK4—liver—hypothyroidism	0.00143	0.00631	CbGeAlD
Gefitinib—CSNK1E—cerebellum—hypothyroidism	0.00142	0.00626	CbGeAlD
Gefitinib—MKNK2—testis—hypothyroidism	0.00141	0.00622	CbGeAlD
Gefitinib—IRAK1—testis—hypothyroidism	0.00141	0.00622	CbGeAlD
Gefitinib—ERBB3—liver—hypothyroidism	0.0014	0.00618	CbGeAlD
Gefitinib—IRAK4—cerebellum—hypothyroidism	0.0014	0.00616	CbGeAlD
Gefitinib—MKNK1—testis—hypothyroidism	0.00139	0.00614	CbGeAlD
Gefitinib—STK10—adrenal gland—hypothyroidism	0.00139	0.00611	CbGeAlD
Gefitinib—STK10—blood—hypothyroidism	0.00139	0.00611	CbGeAlD
Gefitinib—MAP2K5—pituitary gland—hypothyroidism	0.00139	0.00611	CbGeAlD
Gefitinib—ERBB3—cerebellum—hypothyroidism	0.00137	0.00604	CbGeAlD
Gefitinib—Arrhythmia—Liotrix—hypothyroidism	0.00137	0.0144	CcSEcCtD
Gefitinib—Alopecia—Liotrix—hypothyroidism	0.00135	0.0143	CcSEcCtD
Gefitinib—STK10—thyroid gland—hypothyroidism	0.00134	0.0059	CbGeAlD
Gefitinib—MKNK2—liver—hypothyroidism	0.00133	0.00588	CbGeAlD
Gefitinib—IRAK1—liver—hypothyroidism	0.00133	0.00588	CbGeAlD
Gefitinib—MKNK1—liver—hypothyroidism	0.00132	0.00581	CbGeAlD
Gefitinib—Dyspnoea—Levothyroxine—hypothyroidism	0.00132	0.0139	CcSEcCtD
Gefitinib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00132	0.0139	CcSEcCtD
Gefitinib—IRAK1—cerebellum—hypothyroidism	0.0013	0.00574	CbGeAlD
Gefitinib—MKNK2—cerebellum—hypothyroidism	0.0013	0.00574	CbGeAlD
Gefitinib—STK10—female gonad—hypothyroidism	0.00129	0.0057	CbGeAlD
Gefitinib—MKNK1—cerebellum—hypothyroidism	0.00129	0.00567	CbGeAlD
Gefitinib—Fatigue—Levothyroxine—hypothyroidism	0.00127	0.0134	CcSEcCtD
Gefitinib—Fatigue—Dextrothyroxine—hypothyroidism	0.00127	0.0134	CcSEcCtD
Gefitinib—MAP2K5—adrenal gland—hypothyroidism	0.00124	0.00546	CbGeAlD
Gefitinib—MAP2K5—blood—hypothyroidism	0.00124	0.00546	CbGeAlD
Gefitinib—Angioedema—Liotrix—hypothyroidism	0.00122	0.0128	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00121	0.0127	CcSEcCtD
Gefitinib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00121	0.0127	CcSEcCtD
Gefitinib—MAP2K5—thyroid gland—hypothyroidism	0.00119	0.00527	CbGeAlD
Gefitinib—ALB—heart—hypothyroidism	0.00118	0.00521	CbGeAlD
Gefitinib—Urticaria—Dextrothyroxine—hypothyroidism	0.00117	0.0124	CcSEcCtD
Gefitinib—Urticaria—Levothyroxine—hypothyroidism	0.00117	0.0124	CcSEcCtD
Gefitinib—Abdominal pain—Levothyroxine—hypothyroidism	0.00117	0.0123	CcSEcCtD
Gefitinib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00117	0.0123	CcSEcCtD
Gefitinib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00117	0.0123	CcSEcCtD
Gefitinib—Body temperature increased—Levothyroxine—hypothyroidism	0.00117	0.0123	CcSEcCtD
Gefitinib—MAP2K5—female gonad—hypothyroidism	0.00115	0.00509	CbGeAlD
Gefitinib—STK10—testis—hypothyroidism	0.00115	0.00506	CbGeAlD
Gefitinib—STK10—liver—hypothyroidism	0.00108	0.00478	CbGeAlD
Gefitinib—Infection—Liotrix—hypothyroidism	0.00108	0.0114	CcSEcCtD
Gefitinib—Shock—Liotrix—hypothyroidism	0.00107	0.0113	CcSEcCtD
Gefitinib—Asthenia—Levothyroxine—hypothyroidism	0.00106	0.0112	CcSEcCtD
Gefitinib—Asthenia—Dextrothyroxine—hypothyroidism	0.00106	0.0112	CcSEcCtD
Gefitinib—STK10—cerebellum—hypothyroidism	0.00106	0.00467	CbGeAlD
Gefitinib—Pruritus—Levothyroxine—hypothyroidism	0.00104	0.011	CcSEcCtD
Gefitinib—Pruritus—Dextrothyroxine—hypothyroidism	0.00104	0.011	CcSEcCtD
Gefitinib—Anorexia—Liotrix—hypothyroidism	0.00104	0.0109	CcSEcCtD
Gefitinib—MAP2K5—testis—hypothyroidism	0.00102	0.00452	CbGeAlD
Gefitinib—Hypotension—Liotrix—hypothyroidism	0.00101	0.0107	CcSEcCtD
Gefitinib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00101	0.0107	CcSEcCtD
Gefitinib—Diarrhoea—Levothyroxine—hypothyroidism	0.00101	0.0107	CcSEcCtD
Gefitinib—ORM1—blood—hypothyroidism	0.00101	0.00443	CbGeAlD
Gefitinib—Dyspnoea—Liotrix—hypothyroidism	0.000968	0.0102	CcSEcCtD
Gefitinib—MAP2K5—liver—hypothyroidism	0.000968	0.00427	CbGeAlD
Gefitinib—MAP2K5—cerebellum—hypothyroidism	0.000946	0.00417	CbGeAlD
Gefitinib—Decreased appetite—Liotrix—hypothyroidism	0.000944	0.00997	CcSEcCtD
Gefitinib—Vomiting—Dextrothyroxine—hypothyroidism	0.000939	0.00991	CcSEcCtD
Gefitinib—Vomiting—Levothyroxine—hypothyroidism	0.000939	0.00991	CcSEcCtD
Gefitinib—Fatigue—Liotrix—hypothyroidism	0.000936	0.00989	CcSEcCtD
Gefitinib—Rash—Levothyroxine—hypothyroidism	0.000931	0.00983	CcSEcCtD
Gefitinib—Rash—Dextrothyroxine—hypothyroidism	0.000931	0.00983	CcSEcCtD
Gefitinib—Dermatitis—Dextrothyroxine—hypothyroidism	0.00093	0.00982	CcSEcCtD
Gefitinib—Dermatitis—Levothyroxine—hypothyroidism	0.00093	0.00982	CcSEcCtD
Gefitinib—Constipation—Liotrix—hypothyroidism	0.000929	0.00981	CcSEcCtD
Gefitinib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000888	0.00938	CcSEcCtD
Gefitinib—ALB—adrenal gland—hypothyroidism	0.000882	0.00389	CbGeAlD
Gefitinib—Nausea—Dextrothyroxine—hypothyroidism	0.000877	0.00926	CcSEcCtD
Gefitinib—Nausea—Levothyroxine—hypothyroidism	0.000877	0.00926	CcSEcCtD
Gefitinib—Urticaria—Liotrix—hypothyroidism	0.000863	0.00911	CcSEcCtD
Gefitinib—Abdominal pain—Liotrix—hypothyroidism	0.000858	0.00906	CcSEcCtD
Gefitinib—Body temperature increased—Liotrix—hypothyroidism	0.000858	0.00906	CcSEcCtD
Gefitinib—ABCG2—adrenal cortex—hypothyroidism	0.000834	0.00368	CbGeAlD
Gefitinib—ABCG2—heart—hypothyroidism	0.000807	0.00356	CbGeAlD
Gefitinib—Hypersensitivity—Liotrix—hypothyroidism	0.0008	0.00845	CcSEcCtD
Gefitinib—ORM1—liver—hypothyroidism	0.000786	0.00347	CbGeAlD
Gefitinib—Asthenia—Liotrix—hypothyroidism	0.000779	0.00823	CcSEcCtD
Gefitinib—Pruritus—Liotrix—hypothyroidism	0.000768	0.00811	CcSEcCtD
Gefitinib—CYP1A1—heart—hypothyroidism	0.000766	0.00338	CbGeAlD
Gefitinib—Diarrhoea—Liotrix—hypothyroidism	0.000743	0.00785	CcSEcCtD
Gefitinib—CYP2C9—heart—hypothyroidism	0.000737	0.00325	CbGeAlD
Gefitinib—ALB—testis—hypothyroidism	0.000729	0.00322	CbGeAlD
Gefitinib—CYP2C19—blood—hypothyroidism	0.00071	0.00313	CbGeAlD
Gefitinib—CYP2C9—cardiovascular system—hypothyroidism	0.000696	0.00307	CbGeAlD
Gefitinib—Vomiting—Liotrix—hypothyroidism	0.00069	0.00729	CcSEcCtD
Gefitinib—ALB—liver—hypothyroidism	0.000689	0.00304	CbGeAlD
Gefitinib—Rash—Liotrix—hypothyroidism	0.000685	0.00723	CcSEcCtD
Gefitinib—Dermatitis—Liotrix—hypothyroidism	0.000684	0.00722	CcSEcCtD
Gefitinib—ABCG2—pituitary gland—hypothyroidism	0.000674	0.00297	CbGeAlD
Gefitinib—Nausea—Liotrix—hypothyroidism	0.000645	0.00681	CcSEcCtD
Gefitinib—ABCG2—adrenal gland—hypothyroidism	0.000602	0.00266	CbGeAlD
Gefitinib—ABCG2—blood—hypothyroidism	0.000602	0.00266	CbGeAlD
Gefitinib—ABCG2—thyroid gland—hypothyroidism	0.000581	0.00256	CbGeAlD
Gefitinib—CYP1A1—blood—hypothyroidism	0.000572	0.00252	CbGeAlD
Gefitinib—ABCG2—female gonad—hypothyroidism	0.000562	0.00248	CbGeAlD
Gefitinib—CYP3A5—blood—hypothyroidism	0.000559	0.00247	CbGeAlD
Gefitinib—CYP2C19—liver—hypothyroidism	0.000555	0.00245	CbGeAlD
Gefitinib—CYP1A1—thyroid gland—hypothyroidism	0.000552	0.00243	CbGeAlD
Gefitinib—CYP2C9—blood—hypothyroidism	0.00055	0.00243	CbGeAlD
Gefitinib—CYP1A1—female gonad—hypothyroidism	0.000533	0.00235	CbGeAlD
Gefitinib—CYP3A5—female gonad—hypothyroidism	0.000521	0.0023	CbGeAlD
Gefitinib—ABCG2—testis—hypothyroidism	0.000498	0.0022	CbGeAlD
Gefitinib—ABCG2—liver—hypothyroidism	0.000471	0.00208	CbGeAlD
Gefitinib—ABCG2—cerebellum—hypothyroidism	0.00046	0.00203	CbGeAlD
Gefitinib—CYP1A1—liver—hypothyroidism	0.000447	0.00197	CbGeAlD
Gefitinib—CYP3A5—liver—hypothyroidism	0.000437	0.00193	CbGeAlD
Gefitinib—CYP2C9—liver—hypothyroidism	0.00043	0.0019	CbGeAlD
Gefitinib—CYP3A4—blood—hypothyroidism	0.00042	0.00185	CbGeAlD
Gefitinib—CYP2D6—blood—hypothyroidism	0.000413	0.00182	CbGeAlD
Gefitinib—ABCB1—adrenal cortex—hypothyroidism	0.000411	0.00181	CbGeAlD
Gefitinib—ABCB1—heart—hypothyroidism	0.000398	0.00176	CbGeAlD
Gefitinib—CYP2D6—female gonad—hypothyroidism	0.000385	0.0017	CbGeAlD
Gefitinib—ABCB1—cardiovascular system—hypothyroidism	0.000376	0.00166	CbGeAlD
Gefitinib—CYP2D6—testis—hypothyroidism	0.000341	0.00151	CbGeAlD
Gefitinib—ABCB1—gonad—hypothyroidism	0.000341	0.0015	CbGeAlD
Gefitinib—ABCB1—pituitary gland—hypothyroidism	0.000333	0.00147	CbGeAlD
Gefitinib—CYP3A4—liver—hypothyroidism	0.000328	0.00145	CbGeAlD
Gefitinib—CYP2D6—liver—hypothyroidism	0.000323	0.00142	CbGeAlD
Gefitinib—CYP2D6—cerebellum—hypothyroidism	0.000315	0.00139	CbGeAlD
Gefitinib—ABCB1—adrenal gland—hypothyroidism	0.000297	0.00131	CbGeAlD
Gefitinib—ABCB1—blood—hypothyroidism	0.000297	0.00131	CbGeAlD
Gefitinib—ABCB1—thyroid gland—hypothyroidism	0.000287	0.00126	CbGeAlD
Gefitinib—ABCB1—female gonad—hypothyroidism	0.000277	0.00122	CbGeAlD
Gefitinib—ABCB1—testis—hypothyroidism	0.000246	0.00108	CbGeAlD
Gefitinib—ABCB1—liver—hypothyroidism	0.000232	0.00102	CbGeAlD
Gefitinib—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000229	0.0159	CbGpPWpGaD
Gefitinib—ABCB1—cerebellum—hypothyroidism	0.000227	0.001	CbGeAlD
Gefitinib—LOC400927-CSNK1E—Circadian rythm related genes—AVP—hypothyroidism	0.000201	0.014	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—CLTC—hypothyroidism	0.000188	0.0131	CbGpPWpGaD
Gefitinib—EGFR—Syndecan-3-mediated signaling events—POMC—hypothyroidism	0.000182	0.0126	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000162	0.0112	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—CLTC—hypothyroidism	0.000162	0.0112	CbGpPWpGaD
Gefitinib—MAP2K5—Insulin Signaling—PIK3C2A—hypothyroidism	0.000152	0.0105	CbGpPWpGaD
Gefitinib—MAP2K5—Integrin-mediated Cell Adhesion—VAV3—hypothyroidism	0.000152	0.0105	CbGpPWpGaD
Gefitinib—MAP2K5—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000151	0.0105	CbGpPWpGaD
Gefitinib—EGFR—Signaling events mediated by PTP1B—PRL—hypothyroidism	0.000148	0.0103	CbGpPWpGaD
Gefitinib—IRAK1—p75 NTR receptor-mediated signalling—VAV3—hypothyroidism	0.000143	0.00992	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.000139	0.00966	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—CLTC—hypothyroidism	0.000134	0.00935	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—VAV3—hypothyroidism	0.000113	0.00788	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—PRL—hypothyroidism	0.000113	0.00786	CbGpPWpGaD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000107	0.00746	CbGpPWpGaD
Gefitinib—CSNK1E—Circadian rythm related genes—AVP—hypothyroidism	0.000106	0.00735	CbGpPWpGaD
Gefitinib—MAP2K5—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000103	0.00717	CbGpPWpGaD
Gefitinib—EGFR—Stabilization and expansion of the E-cadherin adherens junction—IGF1—hypothyroidism	0.0001	0.00697	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—VAV3—hypothyroidism	9.84e-05	0.00684	CbGpPWpGaD
Gefitinib—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	9.79e-05	0.00681	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—VAV3—hypothyroidism	9.26e-05	0.00644	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	9.26e-05	0.00644	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—SH2B3—hypothyroidism	9.01e-05	0.00626	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—VAV3—hypothyroidism	8.88e-05	0.00617	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—PRL—hypothyroidism	8.69e-05	0.00605	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	8.62e-05	0.00599	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.21e-05	0.00571	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	8.09e-05	0.00562	CbGpPWpGaD
Gefitinib—EGFR—SHP2 signaling—IGF1—hypothyroidism	7.75e-05	0.00539	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CLTC—hypothyroidism	7.33e-05	0.0051	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—CLTC—hypothyroidism	6.74e-05	0.00469	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	6.68e-05	0.00465	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—VAV3—hypothyroidism	6.54e-05	0.00455	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—VAV3—hypothyroidism	6.34e-05	0.00441	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—VAV3—hypothyroidism	6.31e-05	0.00438	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—PRL—hypothyroidism	6.29e-05	0.00437	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—PRL—hypothyroidism	5.77e-05	0.00401	CbGpPWpGaD
Gefitinib—MAP2K5—Focal Adhesion—IGF1—hypothyroidism	5.59e-05	0.00389	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CLTC—hypothyroidism	5.58e-05	0.00388	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	5.54e-05	0.00385	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	5.53e-05	0.00385	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.5e-05	0.00383	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—VAV3—hypothyroidism	5.48e-05	0.00381	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—VAV3—hypothyroidism	5.25e-05	0.00365	CbGpPWpGaD
Gefitinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.24e-05	0.00365	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—VAV3—hypothyroidism	5.15e-05	0.00358	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	5.15e-05	0.00358	CbGpPWpGaD
Gefitinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.95e-05	0.00344	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CLTC—hypothyroidism	4.85e-05	0.00337	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CLTC—hypothyroidism	4.81e-05	0.00334	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.56e-05	0.00317	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—VAV3—hypothyroidism	4.51e-05	0.00314	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CLTC—hypothyroidism	4.44e-05	0.00309	CbGpPWpGaD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.25e-05	0.00296	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	4.25e-05	0.00295	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TRH—hypothyroidism	4.19e-05	0.00291	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CLTC—hypothyroidism	4.08e-05	0.00284	CbGpPWpGaD
Gefitinib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.05e-05	0.00282	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.02e-05	0.00279	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CLTC—hypothyroidism	3.77e-05	0.00262	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TSHB—hypothyroidism	3.74e-05	0.0026	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TSHR—hypothyroidism	3.74e-05	0.0026	CbGpPWpGaD
Gefitinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.73e-05	0.00259	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—IYD—hypothyroidism	3.72e-05	0.00259	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CLTC—hypothyroidism	3.7e-05	0.00257	CbGpPWpGaD
Gefitinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	3.7e-05	0.00257	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—VAV3—hypothyroidism	3.6e-05	0.0025	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PRL—hypothyroidism	3.53e-05	0.00245	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—VAV3—hypothyroidism	3.51e-05	0.00244	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—IGF1—hypothyroidism	3.45e-05	0.0024	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.4e-05	0.00236	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—SH2B3—hypothyroidism	3.33e-05	0.00232	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	3.29e-05	0.00229	CbGpPWpGaD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.29e-05	0.00228	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TRH—hypothyroidism	3.26e-05	0.00227	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—VAV3—hypothyroidism	3.18e-05	0.00221	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ATP5O—hypothyroidism	3.16e-05	0.0022	CbGpPWpGaD
Gefitinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.02e-05	0.0021	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—IGF1—hypothyroidism	3e-05	0.00208	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3e-05	0.00208	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—VAV3—hypothyroidism	2.99e-05	0.00208	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.99e-05	0.00208	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CLTC—hypothyroidism	2.98e-05	0.00207	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.97e-05	0.00207	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TPO—hypothyroidism	2.97e-05	0.00207	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TSHB—hypothyroidism	2.91e-05	0.00202	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TSHR—hypothyroidism	2.91e-05	0.00202	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CLTC—hypothyroidism	2.87e-05	0.002	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—PRL—hypothyroidism	2.84e-05	0.00197	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.81e-05	0.00196	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PRL—hypothyroidism	2.74e-05	0.00191	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	2.67e-05	0.00186	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—IYD—hypothyroidism	2.66e-05	0.00185	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—VAV3—hypothyroidism	2.63e-05	0.00183	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SH2B3—hypothyroidism	2.59e-05	0.0018	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TRH—hypothyroidism	2.58e-05	0.00179	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—IYD—hypothyroidism	2.52e-05	0.00175	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	2.49e-05	0.00173	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TRH—hypothyroidism	2.48e-05	0.00173	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CLTC—hypothyroidism	2.47e-05	0.00172	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PRL—hypothyroidism	2.47e-05	0.00172	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.46e-05	0.00171	CbGpPWpGaD
Gefitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.44e-05	0.00169	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CLTC—hypothyroidism	2.39e-05	0.00166	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TRH—hypothyroidism	2.34e-05	0.00163	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TSHB—hypothyroidism	2.3e-05	0.0016	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TSHR—hypothyroidism	2.3e-05	0.0016	CbGpPWpGaD
Gefitinib—ALB—Metabolism—IYD—hypothyroidism	2.29e-05	0.0016	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—VAV3—hypothyroidism	2.29e-05	0.00159	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—VAV3—hypothyroidism	2.27e-05	0.00158	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ATP5O—hypothyroidism	2.27e-05	0.00157	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—PRL—hypothyroidism	2.26e-05	0.00157	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—POMC—hypothyroidism	2.26e-05	0.00157	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TSHB—hypothyroidism	2.21e-05	0.00154	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TSHR—hypothyroidism	2.21e-05	0.00154	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AVP—hypothyroidism	2.2e-05	0.00153	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.2e-05	0.00153	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ATP5O—hypothyroidism	2.14e-05	0.00149	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—POMC—hypothyroidism	2.13e-05	0.00148	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TPO—hypothyroidism	2.13e-05	0.00148	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	2.1e-05	0.00146	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—VAV3—hypothyroidism	2.09e-05	0.00146	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PRL—hypothyroidism	2.09e-05	0.00145	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TSHB—hypothyroidism	2.09e-05	0.00145	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TSHR—hypothyroidism	2.09e-05	0.00145	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TRH—hypothyroidism	2.07e-05	0.00144	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—IYD—hypothyroidism	2.06e-05	0.00143	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SH2B3—hypothyroidism	2.05e-05	0.00142	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TPO—hypothyroidism	2.01e-05	0.0014	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—IYD—hypothyroidism	2.01e-05	0.0014	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—VAV3—hypothyroidism	2e-05	0.00139	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.98e-05	0.00137	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SH2B3—hypothyroidism	1.97e-05	0.00137	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ATP5O—hypothyroidism	1.95e-05	0.00136	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PRL—hypothyroidism	1.92e-05	0.00134	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—IYD—hypothyroidism	1.89e-05	0.00132	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—PRL—hypothyroidism	1.89e-05	0.00131	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—IYD—hypothyroidism	1.88e-05	0.00131	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SH2B3—hypothyroidism	1.87e-05	0.0013	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.86e-05	0.0013	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TSHB—hypothyroidism	1.84e-05	0.00128	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TSHR—hypothyroidism	1.84e-05	0.00128	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TPO—hypothyroidism	1.83e-05	0.00128	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—VAV3—hypothyroidism	1.78e-05	0.00124	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.75e-05	0.00122	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.75e-05	0.00121	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—VAV3—hypothyroidism	1.74e-05	0.00121	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.73e-05	0.0012	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AVP—hypothyroidism	1.71e-05	0.00119	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ATP5O—hypothyroidism	1.71e-05	0.00119	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.7e-05	0.00118	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TPO—hypothyroidism	1.65e-05	0.00114	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SH2B3—hypothyroidism	1.64e-05	0.00114	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.61e-05	0.00112	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPO—hypothyroidism	1.61e-05	0.00112	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.61e-05	0.00112	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CLTC—hypothyroidism	1.6e-05	0.00111	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.6e-05	0.00111	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.59e-05	0.00111	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.53e-05	0.00106	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.53e-05	0.00106	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PRL—hypothyroidism	1.52e-05	0.00106	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPO—hypothyroidism	1.51e-05	0.00105	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.51e-05	0.00105	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPO—hypothyroidism	1.5e-05	0.00104	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PRL—hypothyroidism	1.46e-05	0.00102	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—POMC—hypothyroidism	1.46e-05	0.00102	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IGF1—hypothyroidism	1.41e-05	0.000979	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—VAV3—hypothyroidism	1.4e-05	0.000977	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.39e-05	0.000967	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TRH—hypothyroidism	1.38e-05	0.000961	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TSHB—hypothyroidism	1.38e-05	0.000957	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.36e-05	0.000944	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—VAV3—hypothyroidism	1.35e-05	0.000942	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AVP—hypothyroidism	1.35e-05	0.000941	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AVP—hypothyroidism	1.3e-05	0.000907	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—VAV3—hypothyroidism	1.28e-05	0.000891	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—VAV3—hypothyroidism	1.28e-05	0.000887	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PRL—hypothyroidism	1.26e-05	0.000876	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—IYD—hypothyroidism	1.24e-05	0.000861	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSHB—hypothyroidism	1.23e-05	0.000857	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSHR—hypothyroidism	1.23e-05	0.000857	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AVP—hypothyroidism	1.23e-05	0.000855	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	1.23e-05	0.000853	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PRL—hypothyroidism	1.22e-05	0.000847	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.19e-05	0.000827	CbGpPWpGaD
Gefitinib—EGFR—Immune System—VAV3—hypothyroidism	1.17e-05	0.000811	CbGpPWpGaD
Gefitinib—EGFR—Disease—PRL—hypothyroidism	1.16e-05	0.000809	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—hypothyroidism	1.14e-05	0.000791	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—VAV3—hypothyroidism	1.13e-05	0.000784	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SH2B3—hypothyroidism	1.1e-05	0.000764	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IGF1—hypothyroidism	1.09e-05	0.000761	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AVP—hypothyroidism	1.09e-05	0.000755	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	1.07e-05	0.000743	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.05e-05	0.000732	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.05e-05	0.00073	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SLC5A5—hypothyroidism	1.03e-05	0.000716	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPO—hypothyroidism	9.9e-06	0.000688	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TSHB—hypothyroidism	9.86e-06	0.000686	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	9.36e-06	0.000651	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TSHB—hypothyroidism	9.31e-06	0.000648	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—hypothyroidism	9e-06	0.000625	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	8.79e-06	0.000611	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—hypothyroidism	8.67e-06	0.000603	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IGF1—hypothyroidism	8.65e-06	0.000602	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TSHB—hypothyroidism	8.49e-06	0.00059	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IGF1—hypothyroidism	8.34e-06	0.00058	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	8.3e-06	0.000577	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.19e-06	0.00057	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—hypothyroidism	8.17e-06	0.000568	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRL—hypothyroidism	8.15e-06	0.000567	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IGF1—hypothyroidism	7.89e-06	0.000549	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TSHB—hypothyroidism	7.62e-06	0.00053	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3C2A—hypothyroidism	7.57e-06	0.000526	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VAV3—hypothyroidism	7.54e-06	0.000524	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.47e-06	0.000519	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TSHB—hypothyroidism	7.44e-06	0.000517	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC5A5—hypothyroidism	7.38e-06	0.000513	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AVP—hypothyroidism	7.26e-06	0.000505	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—hypothyroidism	7.22e-06	0.000502	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TSHB—hypothyroidism	7.01e-06	0.000487	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC5A5—hypothyroidism	6.97e-06	0.000485	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TSHB—hypothyroidism	6.95e-06	0.000483	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF1—hypothyroidism	6.94e-06	0.000483	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	6.79e-06	0.000472	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.7e-06	0.000466	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	6.63e-06	0.000461	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC5A5—hypothyroidism	6.36e-06	0.000442	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	6.25e-06	0.000434	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.19e-06	0.000431	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.11e-06	0.000425	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.71e-06	0.000397	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC5A5—hypothyroidism	5.57e-06	0.000387	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—hypothyroidism	5.39e-06	0.000375	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.25e-06	0.000365	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.2e-06	0.000362	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—hypothyroidism	4.83e-06	0.000336	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1—hypothyroidism	4.64e-06	0.000323	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TSHB—hypothyroidism	4.58e-06	0.000319	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.09e-06	0.000284	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—hypothyroidism	3.86e-06	0.000268	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—hypothyroidism	3.65e-06	0.000254	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.43e-06	0.000239	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—hypothyroidism	3.33e-06	0.000231	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—hypothyroidism	2.99e-06	0.000208	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—hypothyroidism	2.91e-06	0.000203	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—hypothyroidism	2.75e-06	0.000191	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—hypothyroidism	2.72e-06	0.000189	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—hypothyroidism	1.8e-06	0.000125	CbGpPWpGaD
